The effects of lyophilization on the stability of liposomes containing 5-FU

被引:122
|
作者
Glavas-Dodov, M
Fredro-Kumbaradzi, E
Goracinova, K
Simonoska, M
Calis, S
Trajkovic-Jolevskaa, S
Hincal, AA
机构
[1] Sv Kiril & Metodij Univ, Fac Pharm, Dept Pharmaceut Technol, Skopje, North Macedonia
[2] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey
关键词
liposomes; 5-FU; lyophilization; cryoprotectants; drug leakage; stability;
D O I
10.1016/j.ijpharm.2004.07.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multilamellar liposomes containing 5-fluorouracil (5-FU) were prepared by modified lipid film hydration method and were lyophilized with or without saccharose as cryoprotectant. The effect of lyophilization on the stability of liposomes was evaluated by comparing the vesicle size, encapsulation efficiency and the drug release rate before and after lyophilization/rehydration. The process of lyophilization, without cryoprotectant, resulted in particle size increase and significant content leakage. By the addition of saccharose, the lipid bilayers become more stable and less permeable to the encapsulated drug, saccharose imparted 5-FU retention of about 80% after lyophilization/rehydration. Freeze-drying did not affect the particle size of liposomes containing saccharose as cryoprotectant. The drug release profiles of rehydrated liposomes followed Higuchi's square root model. Also, the obtained release profiles were all biphasic: a rapid initial drug release phase (burst release of the portion of the drug that leaked out of liposomes during the lyophilization) was followed by a slower, approximately constant drug release phase (zero-order kinetics). (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [1] Effects of 5-FU
    Wigmore, Peter M.
    Mustafa, Sarah
    El-Beltagy, Maha
    Lyons, Laura
    Umka, Jariya
    Bennett, Geoff
    CHEMO FOG: CANCER CHEMOTHERAPY-RELATED COGNITIVE IMPARIMENT, 2010, 678 : 157 - 164
  • [2] 5-FU INDUCED ENCEPHALOPATHY DURING 5-FU CONTAINING REGIMEN FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Kato, K.
    Hokamura, N.
    Akiyoshi, K.
    Honma, Y.
    Iwasa, S.
    Hamaguchi, T.
    Yamada, Y.
    Shimada, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 139 - 139
  • [3] 5-FU induced encephalopathy during 5-FU containing regimen for esophageal squamous cell carcinoma.
    Kato, Ken
    Akiyoshi, Kohei
    Hokamura, Nobukazu
    Igaki, Hiroyasu
    Tachimori, Yuji
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
    Ghanbarzadeh, Saeed
    Valizadeh, Hadi
    Zakeri-Milani, Parvin
    ADVANCED PHARMACEUTICAL BULLETIN, 2013, 3 (01) : 25 - 29
  • [5] Hemodialysis improves 5-FU induced hypreanmonemia with depressed level of conciousness with during 5-FU containing regimen for colon cancer
    Watanabe, Toshiyasu
    Kijima, Sho
    Goto, Mayu
    Koiso, Yasuhiro
    Kawagoe, Naoyuki
    Takemoto, Ikutaka
    Maeda, Tadashi
    Miyazaki, Taito
    Kido, Hidenori
    Honda, Yoshiko
    Kikuchi, Yoshinori
    Ogura, Mariko
    Koike, Junichi
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Funahashi, Kimihiko
    Shimada, Nagato
    Nakajima, Hitoshi
    Urita, Yosihisa
    Shimada, Hiedeaki
    Kaneko, Hironori
    Mizunuma, Nobuyuki
    Sugimoto, Motonobu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 336 - 337
  • [6] 5-FU CARDIOTOXICITY
    SANANI, S
    SPAULDING, MB
    MASUD, ARZ
    CANTY, R
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1123 - 1125
  • [7] Prodrugs of 5-FU
    Kaye, SB
    ANNALS OF ONCOLOGY, 1998, 9 : 23 - 23
  • [8] The cost of 5-FU
    Ryan, RF
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 107 (06) : 1613 - 1613
  • [9] 5-FU: finally!
    Robert, Jacques
    BULLETIN DU CANCER, 2019, 106 (03) : 173 - 174
  • [10] MULTIPLE EFFECTS OF 5-FLOUROURACIL (5-FU) ON IMMUNOCOMPETENCE
    POPLIN, EA
    HEPPNER, GH
    CALABRES.P
    GRISWOLD, DE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 85 - &